Search research articles
Contact Us
Filters
Showing results (171-180 of 375) with videos related to
Page
of 38
Sort By:
Cancer Treatment Reviews
|
June 1, 2025
Key decision factors in second-line therapy: Expert insights on HR+/HER2-metastatic breast cancer post-CDK4/6 inhibitor progression
Roberto Buonaiuto, Andrea Botticelli, Carmen Criscitiello, et al.
Tumori
|
January 6, 2022
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial
Benedetta Conte, Filippo Montemurro, Alessia Levaggi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2021
Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
Andrea Becerril-Gaitan, Bryan F Vaca-Cartagena, Ana S Ferrigno, et al.
Clinical Breast Cancer
|
March 21, 2024
The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA Trial
Veronique Debien, Elisa Agostinetto, Marco Bruzzone, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 16, 2023
Progression-free survival assessment by local investigators versus blinded independent central review in randomized clinical trials in metastatic breast cancer: A systematic review and meta-analysis
Flavia Jacobs, Chiara Molinelli, Diogo Martins-Branco, et al.
Plos One
|
July 13, 2016
What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities
Anna Moretti, Michele Ghidini, Carmine De Angelis, et al.
ESMO Open
|
August 28, 2020
Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis
Mariana Brandão, Christian Maurer, Patricia Klarmann Ziegelmann, et al.
Clinical Medicine Insights. Reproductive Health
|
August 9, 2019
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review
Francesca Poggio, Matteo Lambertini, Claudia Bighin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 8, 2023
Omission of radiation therapy after breast-conserving surgery for biologically favourable tumours in younger patients: The wrong answer to the right question
Icro Meattini, Gustavo Nader Marta, Susan Carroll, et al.
Frontiers in Oncology
|
July 30, 2019
Impact of Taxanes, Endocrine Therapy, and Deleterious Germline <i>BRCA</i> Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy
Matteo Lambertini, Nathalie Olympios, Justine Lequesne, et al.
Page
of 38
Search research articles
Search
Showing results (171-180 of 375) with videos related to
Sort By:
Page
of 38
Cancer Treatment Reviews
|
June 1, 2025
Key decision factors in second-line therapy: Expert insights on HR+/HER2-metastatic breast cancer post-CDK4/6 inhibitor progression
Roberto Buonaiuto, Andrea Botticelli, Carmen Criscitiello, et al.
Tumori
|
January 6, 2022
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial
Benedetta Conte, Filippo Montemurro, Alessia Levaggi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2021
Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
Andrea Becerril-Gaitan, Bryan F Vaca-Cartagena, Ana S Ferrigno, et al.
Clinical Breast Cancer
|
March 21, 2024
The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA Trial
Veronique Debien, Elisa Agostinetto, Marco Bruzzone, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 16, 2023
Progression-free survival assessment by local investigators versus blinded independent central review in randomized clinical trials in metastatic breast cancer: A systematic review and meta-analysis
Flavia Jacobs, Chiara Molinelli, Diogo Martins-Branco, et al.
Plos One
|
July 13, 2016
What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities
Anna Moretti, Michele Ghidini, Carmine De Angelis, et al.
ESMO Open
|
August 28, 2020
Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis
Mariana Brandão, Christian Maurer, Patricia Klarmann Ziegelmann, et al.
Clinical Medicine Insights. Reproductive Health
|
August 9, 2019
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review
Francesca Poggio, Matteo Lambertini, Claudia Bighin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 8, 2023
Omission of radiation therapy after breast-conserving surgery for biologically favourable tumours in younger patients: The wrong answer to the right question
Icro Meattini, Gustavo Nader Marta, Susan Carroll, et al.
Frontiers in Oncology
|
July 30, 2019
Impact of Taxanes, Endocrine Therapy, and Deleterious Germline <i>BRCA</i> Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy
Matteo Lambertini, Nathalie Olympios, Justine Lequesne, et al.
Page
of 38